Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
11/2003
11/11/2003US6645899 Treating zeolites with vapor phase comprising methanol, a methyl ester, or a methyl halide at molar concentrations ranging from 20-100% molar, at temperature ranging from 250-380 degrees
11/06/2003WO2003091208A1 Lactam synthesizing method
11/06/2003WO2002094799A3 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/06/2003WO2002076375A3 Process for the preparation of benazepril
11/06/2003WO2002051983A3 Novel compounds and compositions as cathepsin inhibitors
11/06/2003US20030207894 1,4-Disubstituted benzenes as insecticides
11/05/2003EP1153006B1 Stabilised compositions of o- and n-vinyl compounds and the use of ammonium salts as stabilisers
11/05/2003CN1453271A Method of eleminating miniature amount of impurities in epsilon-caprolactam water solution
11/05/2003CN1126736C Process for treating lactams and method for purifying lactam
11/04/2003US6642252 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer.
11/04/2003US6642223 Benzoheterocyclic derivatives
10/2003
10/30/2003WO2003088908A2 Heterocyclo inhibitors of potassium channel function
10/29/2003EP1355894A1 Amidinophenylalanine derivatives as thrombin inhibitors
10/29/2003CN1125816C Method for removing nitrous acid gas
10/23/2003WO2003086306A2 5ht2c receptor modulators
10/23/2003US20030199690 Process for synthesis of D1 receptor antagonists
10/23/2003US20030199494 1,2,3,5-tetrahydrobenzo'c!azepin-4-one derivatives having muscarinic antagonist activity
10/22/2003EP1353910A2 Lactam compound
10/22/2003EP1353902A2 Inhibitors of serine protease activity of matriptase or mtsp1
10/22/2003EP1353898A2 Compounds to treat alzheimer's disease
10/22/2003CN1450988A Process for preparing 6-aminocaproamide
10/22/2003CN1125053C Method of preparing norbenzomorphane as an intermediate in the preparation of pharmaceutically useful benzomorphane derivatives in particular
10/21/2003US6635661 Heterocyclic analgesic compounds and methods of use thereof
10/21/2003US6635632 Alzheimer's disease
10/21/2003US6635151 Refluxing aqueous mixtures of caprolactam and ammonia from cyclization of aminocapronitrile, to remove water
10/21/2003CA2262159C A process for preparing carbamazepine from iminostilbene
10/16/2003WO2003084932A1 Method for preparing 6-aminomethyl-6,11-dihydro-5h-dibenz[b,e]azepine
10/16/2003WO2003037271A3 Compounds, pharmaceutical compositions and methods of use therefor
10/16/2003WO2002100849A3 Novel nitriles useful as reversible inhibitors of cysteine proteases
10/16/2003WO2002076939A3 Cysteine protease inhibitors
10/16/2003WO2002055493A9 METHOD FOR STORING AND TRANSPORTING N-VINYL-ε-CAPROLACTAM
10/16/2003US20030195187 For therapy of obesity or type II diabetes
10/15/2003EP1351941A1 Bisaryl derivatives having fsh receptor modulatory activity
10/15/2003EP1351938A1 Phenyl derivatives
10/15/2003EP1351931A1 METHOD FOR STORING AND TRANSPORTING N-VINYL-$g(e)-CAPROLACTAM
10/15/2003EP1351928A2 Novel n(phenylsulphonyl)glycine derivatives and their therapeutic use
10/15/2003CN1449386A Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
10/15/2003CN1124266C Azacyclooctane and heptane derivatives, their preparation and usein therapy
10/14/2003US6632812 Substituted lactams as inhibitors of Aβ protein production
10/14/2003US6632811 Administering cycloalkyl, lactam, lactone compounds for for inhibiting beta -amyloid peptide release and/or its synthesis in a cell
10/09/2003WO2003082808A1 Benzamide derivatives
10/09/2003WO2003082260A2 Tuberculosis treatment using pleuromutilin derivatives
10/09/2003US20030191111 Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
10/08/2003CN1447789A Compounds to treat alzheimer's disease
10/08/2003CN1123567C Prepn. of N-(3-halogeno-propyl)-imino stilbene
10/07/2003US6630599 Process for preparing derivatives of isopropenyl-α, α-dimethylbenzyl isocyanate
10/07/2003US6630472 Compounds, pharmaceutical compositions, and methods for stimulating neuronal growth and elongation
10/07/2003US6630462 Delta agonist analgesics
10/07/2003US6630004 Ready-to-use dyeing composition for keratinous fibers comprising, in dyeing medium, oxidizing agent chosen from hydrogen peroxide, urea hydrogen peroxide, alkali metal bromates, persalts and enzymes, and specified oxidation base
10/02/2003WO2003079975A2 Process for the manufacture of optically active 3-substituted lactams by asymmetric hydrogenation of 3-alkylidenelactams
10/02/2003US20030186967 Anticancer agents; antiinflammatory agents; bone disorders; viricides
10/02/2003US20030186958 Viricides, vision defects, oral diseases, antiarthritic agents, multiple sclerosis, anticancer agents
10/01/2003EP1347967A1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
10/01/2003EP1347950A1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses
10/01/2003CN1122670C Thiazolobenzoheterocycles, prepn method and medicines containing same
09/2003
09/25/2003WO2003078358A2 Use of microfabricated devices for radiosynthesis
09/25/2003WO2003029199A9 Benzene derivatives, process for preparing the same and use thereof
09/25/2003US20030181716 Novel azepane derivatives
09/24/2003EP1345908A2 Process for the preparation of alpha-aminosubstituted carboxylic acid amides
09/24/2003EP1345607A1 Therapeutic combination of amlodipine and benazepril / benazeprilat
09/24/2003EP1098705B1 Method for reactivating a catalyst for cyclizing hydrolysis of an aminonitrile into a lactam and use of the regenerated catalyst for making lactams
09/24/2003CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor
09/24/2003CN1444481A Protease inhibitors
09/23/2003US6624303 By reacting the corresponding NH-amides with acetylenes in the liquid phase using a basic alkali metal compound as catalyst and as cocatalyst (di- or tri-)1,4-butanediol mono- and diethers; N-vinyl-2-pyrrolidone from pyrrolidone
09/23/2003CA2207942C Preparation of caprolactam
09/18/2003WO2003076429A2 Azepane derivatives and their use as atk1 inhibitors
09/18/2003US20030176713 Process for the production of sulfonic esters
09/18/2003US20030176711 Process for the production of sulfonic esters
09/18/2003CA2478276A1 Azepane derivatives and their use as atk1 inhibitors
09/17/2003EP1343796A2 Compounds and methods
09/17/2003EP0984777B1 Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia
09/16/2003CA2068089C Method and compositions for using non-ionic contrast agents to reduce the risk of clot formulation in diagnostic procedures
09/12/2003WO2003074474A2 Multiple-component solid phases containing at least one active pharmaceutical ingredient
09/12/2003CA2477923A1 Multiple-component solid phases containing at least one active pharmaceutical ingredient
09/11/2003US20030171358 New compounds, their preparation and use
09/10/2003EP1341755A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours
09/10/2003EP1341531A2 Lactam compound to inhibit beta-amyloid peptide release or synthesis
09/10/2003EP1127047B1 Hemihydrogenation method for dinitriles
09/10/2003CN1441785A Tetrahydroixoquinoline analogs useful as growth hormone secretagogues
09/04/2003US20030166701 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
09/04/2003US20030166685 Acid derivatives of benzene useful as anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer
09/04/2003US20030166636 Hydroxyalkanoylaminolactams and related structures as inhibitors of A-beta protein production
09/03/2003EP1339670A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
09/02/2003US6613791 N-substituted azaheterocyclic carboxylic acids and their use
08/2003
08/28/2003WO2003070704A1 Method for the preparation of ethylenically unsaturated compounds with lactam-blocked isocyanate groups
08/28/2003WO2002040451A3 Lactam compound
08/28/2003US20030162966 Reacting an amino alcohol derivative with a sulfonyl halide in a mixed solvent composed of an aprotic organic solvent and water in the presence of a non- water-prohibiting inorganic base to produce sulfonic acid ester derivative
08/28/2003US20030162964 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
08/28/2003US20030162811 Heterocyclic amines such as 4-(3'-Thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
08/28/2003US20030162772 For example, N-(2-(3-((1-(3,4-dichlorobenzylpiperidinyl) aminohydroxypropoxy)phenyl)acetamide; use as modulators of chemokine receptor activity, and may be used in treatment of autoimmune, inflammatory, proliferative diseases
08/27/2003EP1337575A1 Modified polylactam
08/27/2003EP1337254A2 Use of weak opioids and mixed opioid agonists/antagonists for treating urinary incontinence
08/27/2003EP1337251A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors
08/27/2003EP0815084B1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease
08/27/2003CN1119334C Substsituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of disease charaterized by abnomal cell proliferation
08/27/2003CN1119333C Process for hydrorefining caprolactam
08/27/2003CN1119332C Intermediate of azepine
08/27/2003CN1119328C Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists
08/21/2003WO2003068753A1 N-carbamoyl nitrogen-containing fused ring compounds and drugs containing these compounds as the active ingredient
08/21/2003WO2003068752A1 Benzenesulfonamide derivatives as antipsychotic agents
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 88